Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.
about
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Triple therapy in COPD: new ev ...... e, and glycopyrronium bromide.
@en
Triple therapy in COPD: new ev ...... e, and glycopyrronium bromide.
@nl
type
label
Triple therapy in COPD: new ev ...... e, and glycopyrronium bromide.
@en
Triple therapy in COPD: new ev ...... e, and glycopyrronium bromide.
@nl
prefLabel
Triple therapy in COPD: new ev ...... e, and glycopyrronium bromide.
@en
Triple therapy in COPD: new ev ...... e, and glycopyrronium bromide.
@nl
P2093
P2860
P921
P356
P1476
Triple therapy in COPD: new ev ...... e, and glycopyrronium bromide.
@en
P2093
Alberto Papi
Dave Singh
Jørgen Vestbo
Mario Scuri
Massimo Corradi
Monica Spinola
Omar S Usmani
Stefano Petruzzelli
P2860
P304
P356
10.2147/COPD.S146822
P407
P577
2017-10-06T00:00:00Z